borderline significantp < .05
A dose‐dependent effect on the relative bioavailability was incorporated into the model a priori and showed a borderline significant improvement in model fit ( p < .05, ∆OFV = −3.95).
A dose‐dependent effect on the relative bioavailability was incorporated into the model a priori and showed a borderline significant improvement in model fit ( p < .05, ∆OFV = −3.95).